Privi Overview
- Founded
- 2014
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
Privi General Information
Description
Developer of a medical device intended to alleviate pain caused by hemorrhoids. The company's device helps to alleviate and reduce the recurrence of bleeding and painful symptoms caused by hemorrhoids, thereby enabling patients to get cured without any side effects.
Contact Information
Primary Industry
Therapeutic Devices
Acquirer
HeMo Bioengineering
Primary Office
- AStart Central
- Blk 79 Ayer Crescent Drive, Number 05-03
- Singapore, 139955
- Singapore
Privi Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 28-Oct-2021 | 00000 | Completed | Generating Revenue | ||
| 2. Early Stage VC | 00000 | 00000 | Completed | Startup | ||
| 1. Grant | 01-Dec-2014 | $77.1K | Completed | Startup |
Privi Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| NTUC Income | Corporation | Minority | 000 0000 | 000000 0 |